A cohort study of patients with impaired cognitive ability suggested that glial fibrillary acidic protein (GFAP), a potential blood-based biological marker, also called biomarker, can predict decline of cognitive ability associated with Alzheimer’s disease. This study showed the power of blood GFAP in predicting cognitive decline among patients with impaired cognitive ability. Current methods used […]
Increased Blood Levels of GFAP May Track Alzheimer’s Disease Progression Before Cognitive Symptoms Occur
In a study with people who had normal cognitive ability, researchers found that the blood levels of glial fibrillary acidic protein (GFAP) increased more rapidly in people at risk of future Alzheimer’s disease than those without the risk of the disease. Protein GFAP locates in the cells that support the nerve cells in the central […]
Read Time:
5 Min
Six Months of Personalized Medicine Care Plan Improved Cognitive Ability in People with Mild Cognitive Impairment
Personalized medicine care plans improved cognitive ability of people with mild cognitive impairment significantly after six months, a study shows. The care plans modified the participants’ lifestyle, diet habits, and supplements intake, as well as prescription medications for their existing conditions. The findings suggest that a holistic, personalized medicine care plan can improve cognitive ability. […]
Read Time:
5 Min